Rasagiline

In the US, Rasagiline (rasagiline systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease.

US matches:

• Rasagiline
• Rasagiline Mesylate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04BD02

CAS registry number (Chemical Abstracts Service)

0136236-51-6

Chemical Formula

C12-H13-N

Molecular Weight

171

Therapeutic Categories

Treatment of Parkinson's disease

Inhibitor of monoamin oxidase type B (MAO-B)

Chemical Names

(R)-N-2-propynyl-1-indanamine

N-propargyl-1-(R)-aminoindan

Foreign Names

• Rasagilinum (Latin)
• Rasagilin (German)
• Rasagiline (French)
• Rasagilina (Spanish)

Generic Names

• Rasagiline (OS: USAN)
• Rasagiline Mesylate (OS: USAN)
• AGN-1135 (IS)
• Rasagiline methanesulfonate (IS)
• TVP 1012 (IS: Teva)
• TVP-101 (IS)

Brand Names

• Azilect
  Lundbeck, Denmark; Lundbeck, Latvia; Lundbeck, Turkey; Teva, Slovakia; Teva Pharmaceuticals, Poland
• Parkintreat
  Inspire Ph, Egypt
• Ralago
  KRKA, Slovenia
• Rangar
  Productos Farmaceuticos Medipharm, Chile
• Rasagiline Amneal
  Amneal, Netherlands
• Rasagiline Aurobindo
  Aurobindo, Netherlands
• Rasagiline BioOrganics
  BioOrganics, Netherlands
• Rasagiline CF
  Centrafarm, Netherlands
• Rasagiline DOC Generici
  DOC Generici, Netherlands
• Rasagiline Genericon
  Genericon, Netherlands
• Rasagiline Genthon
  Genthon, Netherlands
• Rasagiline Krka
  Krka, Netherlands
• Rasagiline Sandoz
  Sandoz, Netherlands
• Rasagiline Synthon
  Synthon, Netherlands
• Rasalin
  Vianex, Netherlands
• Rasax
  AstraZeneca, Argentina
• Agilect
  Teva, United States
• Azilect
  Lundbeck, Australia; Lundbeck, Belgium; Lundbeck, Spain; Lundbeck, Finland; Lundbeck, France; Lundbeck, Croatia (Hrvatska); Lundbeck, Ireland; Lundbeck, Sweden; Lundbeck, Thailand; Lundbeck, South Africa; Lundbeck Italia, Italy; Teva, Austria; Teva, Czech Republic; Teva, Greece; Teva, Hungary; Teva, Israel; Teva, Iceland; Teva, Lithuania; Teva, Mexico; Teva, Norway; Teva, Romania; Teva, Serbia; Teva, United States; Teva Canada Innovation, Canada; Teva Pharma, Switzerland; Teva Pharma, Cyprus; Teva Pharma, Germany; Teva Pharma, Portugal; Teva Pharmaceuticals, United Kingdom
• Elbrus
  Laboratorios Raffo, Chile; Roemmers, Argentina
• Menuix
  Pharma Investi de Chile, Chile; Roemmers Centroamérica, Guatemala; Roemmers Centroamérica, Honduras; Roemmers Centroamérica, Nicaragua; Roemmers Centroamérica, Panama; Roemmers Centroamérica, El Salvador
• Rasagilina Richet
  Richet, Argentina
• Rasagilin-Mepha
  Mepha Pharma, Switzerland

Glossary

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer